Free press releases distribution network?

Agency / Source: Report Buyer Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Top Companies in Global Infectious Disease Treatment Market Need to Re-think Tactics Says New Report - Report Buyer has a new report which finds that some top companies will need to re-evaluate strategy as there is a slowdown in the infectious disease treatment market
Top Companies in Global Infectious Disease Treatment Market Need to Re-think Tactics Says New Report

 

PRZOOM - /newswire/ - London, United Kingdom, 2008/03/10 - Report Buyer has a new report which finds that some top companies will need to re-evaluate strategy as there is a slowdown in the infectious disease treatment market.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that some top companies will need to re-evaluate strategy as the growth rates for the $38bn infectious disease market has fallen over the 2005-2006 period.

The report, "Commercial Insight: Infectious Diseases Overview" finds that 10 players account for two thirds of seven major market chemotherapeutic anti-infective sales by value, but just one third by volume. It says that these companies have, collectively, been worst hit by the market slowdown, making it necessary for them to implement key changes.

Authors of the report say that the core competencies of these companies range from a single disease area to prowess in the generics field. This report characterises the key players in each sector, and their approach to maximising returns from a pressurised sector.

Analysts provide an inter and intra-sector overview of the four major components of the chemotherapeutic anti-infectives market in Japan, the US, and EU.

The report provides the disease backgrounds for each sector, drawing attention to the key clinical issues and unmet needs that shape commercial strategies for success. It outlines market size, structure, brand and company orientation by sector and highlights the winning tactics and strategies in portfolio management.

The study finds that the sluggish market has placed an increased emphasis on high value niches of the market, and the need for effective tactics to ensure revenue loss minimisation (including, for example, OTC leveraging), line extension and product succession in different measures.
The report highlights the elements of strategies that have either kept players at the top of their field or failed to facilitate growth. It also provides pointers on how businesses should position their products and services.

"Commercial Insight: Infectious Diseases Overview" is available from Report Buyer.
For more information see website.

Report Buyer product ID: DAT09488

Report Buyer is a UK-based independent online store supplying business information. The website now carries over 44,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Report Buyer Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Top Companies in Global Infectious Disease Treatment Market Need to Re-think Tactics Says New Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Urmila Doraswami 
+44 (0) 20 7060 7474 press[.]reportbuyer.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Report Buyer Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  Intrinsic Executive Search Ltd

Visit  Al Rowaad Advocates & Legal Consultants







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today